Biopsy Devices Market Size is valued at USD 6.84 Bn in 2023 and is predicted to reach USD 20.04 Bn by the year 2031 at a 14.51% CAGR during the forecast period for 2024-2031.
A biopsy is a surgical procedure that takes tissue from an organ to detect the presence or extent of disease, most commonly malignant and inflammatory conditions. The most common people who carry it out are radiologists, surgeons, and interventional cardiologists. Biopsies are used to perform on any organ using specific biopsy instruments as a confirming test for cancer and celiac disease. The application of each biopsy equipment differs depending on the type of organ under consideration. The rising global cancer prevalence, untapped potential in emerging nations, particularly in Asia Pacific, and the improvement of healthcare infrastructure in these regions are among the important themes driving market growth.
However, the COVID-19 pandemic had a moderate impact on the market. Prioritizing cancer patients was difficult because healthcare personnel were mostly focused on COVID-19 patients. With a greater emphasis on avoiding viral infection, most people preferred fewer trips to healthcare settings. To some extent, this had a negative impact on the biopsy market. However, once the globe returned to normalcy and cancer cases increased, the market swiftly rebounded.
The Biopsy Devices Market is segmented based on Product Type, Biopsy Type, Disease Type, Anatomy, and Guidance Technique. By Product Type segment comprises Needle Biopsy Devices (Guidance Systems, Biopsy Consoles, Site Markers, Biopsy Guns (Automated Systems, Semi-Automated Systems), Needles), Skin Biopsy Devices (Punch Biopsy Instruments, Shave Biopsy Instruments), and Consumables (Forceps, Trocars, Trays, Other Consumables). Whereas the Biopsy Type segment consists of Tissue Biopsy, which is again divided into Needle Biopsy, Surgical Biopsy and Skin Biopsy, and Liquid Biopsy. The Anatomy segment includes Breast, Lung, Bone, Liver, Uterus/Cervix/Ovary, Abdomen, Prostate, Cardiac, Skin, and Others. By Disease Type, the market is segmented into Cancer, Infections, Autoimmune Disorders, Non-Cancerous Indications, and Others. According to the Guidance Technique segment, the market is divided into Growth-Share Analysis, Ultrasound-Guided Biopsy, X-Ray-Guided Biopsy, MRI-Guided Biopsy, and CT-Guided Biopsy.
The needle biopsy devices sector held the most significant portion of the market. Needle biopsies are characterized by their minimally invasive nature, allowing for prompt execution while minimizing patient distress. As a result, they are favored by healthcare providers and patients alike. Furthermore, the escalating prevalence of cancer and the imperative for timely detection have heightened the need for tissue sampling, specifically for lesions that are conventionally challenging to access.
The Breast anatomy segment is projected to grow rapidly in the global Biopsy Devices Market. The current domination of this category is mostly because of the availability of many cancer therapies monitoring liquid biopsies that key players now offer.
The North America Biopsy Devices Market is expected to record the maximum market share in revenue in the near future. Owing to the existence of established market players in the region, it is expected to continue to account for a sizable part of the market throughout the projection period. The regional market will likely benefit from high market penetration rates of technologically advanced equipment such as vacuum-assisted biopsy systems and rapidly expanding demand for disposable devices. Asia Pacific offers numerous prospects for market expansion. The rapid improvement of healthcare infrastructure in growing Asia Pacific countries, the prevalence of significant unmet patient demands, and the rising incidence of cancer are expected to drive regional market expansion.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 6.84 Bn |
| Revenue Forecast In 2031 | USD 20.04 Bn |
| Growth Rate CAGR | CAGR of 14.51% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product Type, By Biopsy Type, By Anatomy, By Disease Type, By Guidance Technique |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Argon Medical Devices, Inc., B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Conmed Corporation, FUJIFILM Holdings Corporation, GE Healthcare, Inrad, Inc., Medtronic plc, Olympus Corporation, Siemens Healthineers AG, Stryker Corporation, Zamar Care, Changzhou Jiuhong Medical Instrument Co., Ltd., Kindly (KDL) Meditech, Ningbo Xinwell Medical Technology Co., LTD., Shenzhen Manners Technology Co., Ltd., Zhejiang Soudon Medical Technology Co., Ltd, Agilent Technologies, Inc., BGI Group, Biocept, Inc., Bio-Rad Laboratories, Inc., Dxcover Limited, Elypta Limited, F. Hoffmann-La Roche Ltd, Illumina, Inc., Micronoma, QIAGEN, Revvity, Inc., Sysmex Corporation, and Thermo Fisher Scientific Inc. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Biopsy Devices Market By Product Type-
Biopsy Devices Market By Biopsy Type
Biopsy Devices Market By Anatomy-
Biopsy Devices Market By Disease Type-
Biopsy Devices Market By Guidance Technique -
Biopsy Devices Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biopsy Devices Market Snapshot
Chapter 4. Global Biopsy Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:
5.2.1. Needle Biopsy Devices
5.2.1.1. Guidance Systems
5.2.1.2. Biopsy Consoles
5.2.1.3. Site Markers
5.2.1.4. Biopsy Guns
5.2.1.4.1. Automated Systems
5.2.1.4.2. Semi-Automated Systems
5.2.1.5. Needles
5.2.2. Skin Biopsy Devices
5.2.2.1. Punch Biopsy Instruments
5.2.2.2. Shave Biopsy Instruments
5.2.3. Consumables
5.2.3.1. Forceps
5.2.3.2. Trocars
5.2.3.3. Trays
5.2.3.4. Other Consumables
Chapter 6. Market Segmentation 2: By Biopsy Type Estimates & Trend Analysis
6.1. By Biopsy Type & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Biopsy Type:
6.2.1. Tissue Biopsy
6.2.1.1. Needle Biopsy
6.2.1.2. Skin Biopsy
6.2.1.3. Surgical Biopsy
6.2.2. Liquid Biopsy
Chapter 7. Market Segmentation 3: By Disease Type Estimates & Trend Analysis
7.1. By Disease Type & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Disease Type:
7.2.1. Cancer
7.2.2. Infections
7.2.3. Autoimmune Disorders
7.2.4. Non-Cancerous Indications
7.2.5. Others
Chapter 8. Market Segmentation 4: By Anatomy Estimates & Trend Analysis
8.1. By Anatomy & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Anatomy:
8.2.1. Breast
8.2.2. Lung
8.2.3. Bone
8.2.4. Liver
8.2.5. Uterus/Cervix/Ovary
8.2.6. Abdomen
8.2.7. Prostate
8.2.8. Cardiac
8.2.9. Skin
8.2.10. Others
Chapter 9. Market Segmentation 5: By Guidance Technique Estimates & Trend Analysis
9.1. By Guidance Technique & Market Share2019 2020 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Guidance Technique:
9.2.1. X-Ray-Guided Biopsy
9.2.2. Ultrasound-Guided Biopsy
9.2.3. MRI-Guided Biopsy
9.2.4. CT-Guided Biopsy
Chapter 10. Biopsy Devices Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Product, 2024-2031
10.1.2. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Biopsy Type, 2024-2031
10.1.3. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Disease Type, 2024-2031
10.1.4. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Anatomy, 2024-2031
10.1.5. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts By Guidance Technique, 2024-2031
10.1.6. North America Biopsy Devices Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
10.2. Europe
10.2.1. Europe Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.2.2. Europe Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.2.3. Europe Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.2.4. Europe Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.2.5. Europe Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.2.6. Europe Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.3.2. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.3.3. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.3.4. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.3.5. Asia Pacific Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.3.6. Asia Pacific Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
10.4. Latin America
10.4.1. Latin America Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.4.2. Latin America Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.4.3. Latin America Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.4.4. Latin America Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.4.5. Latin America Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.4.6. Latin America Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Product, 2024-2031
10.5.2. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Biopsy Type, 2024-2031
10.5.3. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Disease Type, 2024-2031
10.5.4. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Anatomy, 2024-2031
10.5.5. Middle East & Africa Biopsy Devices Market revenue (US$ Million) By Guidance Technique, 2024-2031
10.5.6. Middle East & Africa Biopsy Devices Market revenue (US$ Million) by country, 2024-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Argon Medical Devices, Inc.
11.2.2. B. Braun SE
11.2.3. Becton, Dickinson and Company
11.2.4. Boston Scientific Corporation
11.2.5. Cardinal Health, Inc.
11.2.6. Cook Group Incorporated
11.2.7. Conmed Corporation
11.2.8. FUJIFILM Holdings Corporation
11.2.9. GE Healthcare
11.2.10. Inrad, Inc.
11.2.11. Medtronic plc
11.2.12. Olympus Corporation
11.2.13. Siemens Healthineers AG
11.2.14. Stryker Corporation
11.2.15. Zamar Care
11.2.16. Changzhou Jiuhong Medical Instrument Co., Ltd.
11.2.17. Kindly (KDL) Meditech
11.2.18. Ningbo Xinwell Medical Technology Co., LTD.
11.2.19. Shenzhen Manners Technology Co., Ltd.
11.2.20. Zhejiang Soudon Medical Technology Co., Ltd
11.2.21. Agilent Technologies, Inc.
11.2.22. BGI Group
11.2.23. Biocept, Inc.
11.2.24. Bio-Rad Laboratories, Inc.
11.2.25. Dxcover Limited
11.2.26. Elypta Limited
11.2.27. F. Hoffmann-La Roche Ltd
11.2.28. Illumina, Inc.
11.2.29. Micronoma
11.2.30. QIAGEN
11.2.31. Revvity, Inc.
11.2.32. Sysmex Corporation
11.2.33. Thermo Fisher Scientific Inc.